Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Jamie Greenfield

Showing results (11-20 of 20) with videos related to

Pageof 2
Sort By:
You have reached the last page of results.This site can display upto 20 results.
Multiple Sclerosis and Related Disorders|March 10, 2024
Feasibility study to assess lesion repair in relapsing-remitting multiple sclerosis: A randomized controlled pilot clinical trial of domperidone add-on treatmentYunyan Zhang, Wei-Qiao Liu, Zahra Hosseinpour, et al.
The Canadian Journal of Neurological Sciences. Le Journal Canadien Des Sciences Neurologiques|February 19, 2016
Medical Tourism for CCSVI Procedures in People with Multiple Sclerosis: An Observational StudyLuanne M Metz, Jamie Greenfield, Ruth Ann Marrie, et al.
Multiple Sclerosis (Houndmills, Basingstoke, England)|July 18, 2022
Minocycline treatment in clinically isolated syndrome and serum NfL, GFAP, and metalloproteinase levelsCarlos Camara-Lemarroy, Luanne Metz, Jens Kuhle, et al.
Journal of Neuroimaging : Official Journal of the American Society of Neuroimaging|June 15, 2021
Nonlesional diffusely abnormal appearing white matter in clinically isolated syndrome: Prevalence, association with clinical and MRI features, and risk for conversion to multiple sclerosisR Davis Holmes, Irene M Vavasour, Jamie Greenfield, et al.
Multiple Sclerosis and Related Disorders|November 4, 2023
Cancer risk, disease-modifying therapy, and age in multiple sclerosis: A retrospective population-based cohort studyJamie Greenfield, Luanne M Metz, Amir Khakban, et al.
Multiple Sclerosis and Related Disorders|February 13, 2021
Multimodal peripheral fluid biomarker analysis in clinically isolated syndrome and early multiple sclerosisCarlos R Camara-Lemarroy, Claudia Silva, Luanne M Metz, et al.
Brain and Behavior|October 1, 2016
Physical comorbidities increase the risk of psychiatric comorbidity in multiple sclerosisRuth Ann Marrie, Scott B Patten, Jamie Greenfield, et al.
Plos One|April 14, 2015
Long-term persistence with injectable therapy in relapsing-remitting multiple sclerosis: an 18-year observational cohort studySimon Zhornitsky, Jamie Greenfield, Marcus W Koch, et al.
CMAJ Open|June 19, 2021
Assessing the efficacy and safety of hydroxychloroquine as outpatient treatment of COVID-19: a randomized controlled trialIlan Schwartz, Mari E Boesen, Graziela Cerchiaro, et al.
The New England Journal of Medicine|June 1, 2017
Trial of Minocycline in a Clinically Isolated Syndrome of Multiple SclerosisLuanne M Metz, David K B Li, Anthony L Traboulsee, et al.
Pageof 2

Showing results (11-20 of 20) with videos related to

Sort By:
Pageof 2
You have reached the last page of results.This site can display upto 20 results.
Multiple Sclerosis and Related Disorders|March 10, 2024
Feasibility study to assess lesion repair in relapsing-remitting multiple sclerosis: A randomized controlled pilot clinical trial of domperidone add-on treatmentYunyan Zhang, Wei-Qiao Liu, Zahra Hosseinpour, et al.
The Canadian Journal of Neurological Sciences. Le Journal Canadien Des Sciences Neurologiques|February 19, 2016
Medical Tourism for CCSVI Procedures in People with Multiple Sclerosis: An Observational StudyLuanne M Metz, Jamie Greenfield, Ruth Ann Marrie, et al.
Multiple Sclerosis (Houndmills, Basingstoke, England)|July 18, 2022
Minocycline treatment in clinically isolated syndrome and serum NfL, GFAP, and metalloproteinase levelsCarlos Camara-Lemarroy, Luanne Metz, Jens Kuhle, et al.
Journal of Neuroimaging : Official Journal of the American Society of Neuroimaging|June 15, 2021
Nonlesional diffusely abnormal appearing white matter in clinically isolated syndrome: Prevalence, association with clinical and MRI features, and risk for conversion to multiple sclerosisR Davis Holmes, Irene M Vavasour, Jamie Greenfield, et al.
Multiple Sclerosis and Related Disorders|November 4, 2023
Cancer risk, disease-modifying therapy, and age in multiple sclerosis: A retrospective population-based cohort studyJamie Greenfield, Luanne M Metz, Amir Khakban, et al.
Multiple Sclerosis and Related Disorders|February 13, 2021
Multimodal peripheral fluid biomarker analysis in clinically isolated syndrome and early multiple sclerosisCarlos R Camara-Lemarroy, Claudia Silva, Luanne M Metz, et al.
Brain and Behavior|October 1, 2016
Physical comorbidities increase the risk of psychiatric comorbidity in multiple sclerosisRuth Ann Marrie, Scott B Patten, Jamie Greenfield, et al.
Plos One|April 14, 2015
Long-term persistence with injectable therapy in relapsing-remitting multiple sclerosis: an 18-year observational cohort studySimon Zhornitsky, Jamie Greenfield, Marcus W Koch, et al.
CMAJ Open|June 19, 2021
Assessing the efficacy and safety of hydroxychloroquine as outpatient treatment of COVID-19: a randomized controlled trialIlan Schwartz, Mari E Boesen, Graziela Cerchiaro, et al.
The New England Journal of Medicine|June 1, 2017
Trial of Minocycline in a Clinically Isolated Syndrome of Multiple SclerosisLuanne M Metz, David K B Li, Anthony L Traboulsee, et al.
Pageof 2